Marina Keul

781 total citations
16 papers, 307 citations indexed

About

Marina Keul is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Marina Keul has authored 16 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Marina Keul's work include Lung Cancer Treatments and Mutations (12 papers), HER2/EGFR in Cancer Research (9 papers) and Cancer therapeutics and mechanisms (6 papers). Marina Keul is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), HER2/EGFR in Cancer Research (9 papers) and Cancer therapeutics and mechanisms (6 papers). Marina Keul collaborates with scholars based in Germany, Netherlands and United States. Marina Keul's co-authors include Daniel Rauh, Jonas Lategahn, Julian Engel, Hannah L. Tumbrink, Sebastian Bauer, Carsten Schultz‐Fademrecht, Julia Ketzer, Thomas Mühlenberg, Eva Döring and Michael Juchum and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Oncology and Journal of Medicinal Chemistry.

In The Last Decade

Marina Keul

15 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marina Keul Germany 9 211 144 123 110 30 16 307
Michael Juchum Germany 7 262 1.2× 150 1.0× 187 1.5× 146 1.3× 27 0.9× 10 376
Xiao-E Yan China 9 173 0.8× 117 0.8× 158 1.3× 139 1.3× 37 1.2× 10 321
Rich Woessner United States 9 161 0.8× 86 0.6× 96 0.8× 131 1.2× 34 1.1× 17 326
Tyler S. Beyett United States 11 237 1.1× 82 0.6× 96 0.8× 108 1.0× 52 1.7× 25 369
Takumitsu Machida Japan 8 192 0.9× 141 1.0× 47 0.4× 143 1.3× 57 1.9× 10 361
Jacob I. Contreras United States 10 344 1.6× 124 0.9× 85 0.7× 195 1.8× 20 0.7× 12 536
Camille Prével France 6 204 1.0× 72 0.5× 100 0.8× 168 1.5× 28 0.9× 8 371
Christopher Meades United Kingdom 6 182 0.9× 119 0.8× 58 0.5× 142 1.3× 32 1.1× 8 347
Gavin Wood United Kingdom 6 156 0.7× 111 0.8× 61 0.5× 123 1.1× 52 1.7× 8 311
Edward J. Lewis United Kingdom 5 223 1.1× 46 0.3× 77 0.6× 150 1.4× 49 1.6× 5 360

Countries citing papers authored by Marina Keul

Since Specialization
Citations

This map shows the geographic impact of Marina Keul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Keul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Keul more than expected).

Fields of papers citing papers by Marina Keul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Keul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Keul. The network helps show where Marina Keul may publish in the future.

Co-authorship network of co-authors of Marina Keul

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Keul. A scholar is included among the top collaborators of Marina Keul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Keul. Marina Keul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Gontla, Rajesh, Thomas Mühlenberg, Marina Keul, et al.. (2025). Design, Synthesis, and SAR of Covalent KIT and PDGFRA Inhibitors─Exploring Their Potential in Targeting GIST. Journal of Medicinal Chemistry. 68(3). 3238–3259.
2.
Sydow, Dominique, et al.. (2021). Analyzing Kinase Similarity in Small Molecule and Protein Structural Space to Explore the Limits of Multi-Target Screening. Molecules. 26(3). 629–629. 8 indexed citations
3.
Lategahn, Jonas, Marina Keul, Hannah L. Tumbrink, et al.. (2020). Targeting Her2-insYVMA with Covalent Inhibitors—A Focused Compound Screening and Structure-Based Design Approach. Journal of Medicinal Chemistry. 63(20). 11725–11755. 12 indexed citations
4.
Sos, Martin L., Hannah L. Tumbrink, Carsten Schultz‐Fademrecht, et al.. (2019). Targeting EGFR Ex20 mutant lung cancer with the wild type sparing kinase inhibitor PRB001.. Journal of Clinical Oncology. 37(15_suppl). e14718–e14718. 1 indexed citations
5.
Fassunke, Jana, Carina Heydt, Sebastian Michels, et al.. (2019). New insights into acquired resistance mechanisms to third-generation EGFR tyrosine kinase inhibitor therapy in lung cancer. Annals of Oncology. 30. ii51–ii51. 1 indexed citations
6.
Weisner, Jörn, et al.. (2018). RASPELD to Perform High‐End Screening in an Academic Environment toward the Development of Cancer Therapeutics. ChemMedChem. 13(19). 2065–2072. 5 indexed citations
7.
Lategahn, Jonas, Marina Keul, & Daniel Rauh. (2017). Lessons To Be Learned: The Molecular Basis of Kinase‐Targeted Therapies and Drug Resistance in Non‐Small Cell Lung Cancer. Angewandte Chemie International Edition. 57(9). 2307–2313. 38 indexed citations
8.
Lategahn, Jonas, Marina Keul, & Daniel Rauh. (2017). Lektion gelernt? Die molekularen Grundlagen von Kinase‐gerichteten Therapien und Wirkstoffresistenz im nicht‐kleinzelligen Lungenkrebs. Angewandte Chemie. 130(9). 2329–2335. 1 indexed citations
9.
Keul, Marina, Thomas Mühlenberg, Julia Ketzer, et al.. (2017). Inhibitors to Overcome Secondary Mutations in the Stem Cell Factor Receptor KIT. Journal of Medicinal Chemistry. 60(21). 8801–8815. 8 indexed citations
10.
Günther, Marcel, Jonas Lategahn, Michael Juchum, et al.. (2017). Trisubstituted Pyridinylimidazoles as Potent Inhibitors of the Clinically Resistant L858R/T790M/C797S EGFR Mutant: Targeting of Both Hydrophobic Regions and the Phosphate Binding Site. Journal of Medicinal Chemistry. 60(13). 5613–5637. 81 indexed citations
11.
Tomassi, Stefano, Jonas Lategahn, Julian Engel, et al.. (2017). Indazole-Based Covalent Inhibitors To Target Drug-Resistant Epidermal Growth Factor Receptor. Journal of Medicinal Chemistry. 60(6). 2361–2372. 46 indexed citations
12.
Smith, Steven P., et al.. (2017). Characterization of Covalent-Reversible EGFR Inhibitors. ACS Omega. 2(4). 1563–1575. 23 indexed citations
13.
Engel, Julian, Steven P. Smith, Jonas Lategahn, et al.. (2017). Structure-Guided Development of Covalent and Mutant-Selective Pyrazolopyrimidines to Target T790M Drug Resistance in Epidermal Growth Factor Receptor. Journal of Medicinal Chemistry. 60(18). 7725–7744. 25 indexed citations
14.
Engel, Julian, Christian Becker, Jonas Lategahn, et al.. (2016). Inhibition wirkstoffresistenter Mutationsvarianten der Rezeptortyrosinkinase EGFR. Angewandte Chemie. 128(36). 11069–11073. 5 indexed citations
15.
Engel, Julian, Christian Becker, Jonas Lategahn, et al.. (2016). Insight into the Inhibition of Drug‐Resistant Mutants of the Receptor Tyrosine Kinase EGFR. Angewandte Chemie International Edition. 55(36). 10909–10912. 52 indexed citations
16.
Becker, Christian, Hoang Duc Nguyen, Trang Thi Phuong Phan, et al.. (2016). Monitoring Conformational Changes in the Receptor Tyrosine Kinase EGFR. ChemBioChem. 17(11). 990–994. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Juchum Breakdown of academic impact, for papers by Xiao-E Yan Breakdown of academic impact, for papers by Rich Woessner Breakdown of academic impact, for papers by Tyler S. Beyett Breakdown of academic impact, for papers by Takumitsu Machida Breakdown of academic impact, for papers by Jacob I. Contreras Breakdown of academic impact, for papers by Camille Prével Breakdown of academic impact, for papers by Christopher Meades Breakdown of academic impact, for papers by Gavin Wood Breakdown of academic impact, for papers by Edward J. Lewis
Rankless by CCL
2026